Minireviews
Copyright ©The Author(s) 2023.
World J Gastroenterol. Mar 7, 2023; 29(9): 1446-1459
Published online Mar 7, 2023. doi: 10.3748/wjg.v29.i9.1446
Table 2 Noncoding RNAs for the potential treatment of liver fibrosis
ncRNAs
Target genes
Signaling pathways
Ref.
miR-29aPI3KP85αPI3K/AKT[79]
FstlTGF-β/Smad2, JNK[21]
miR-223NLRP3 inflammasomeNOD signaling pathway[81]
GLI2, PDGFRα/βHedgehog, PDGF[82]
hB-MSCs-derived exo-miR-618Smad4TGF-β/Smad2 [87]
3DhESCs-derived exo-miR-6766-3pTGFβRIITGF-β/Smad [89]
hT-MSCs-derived exo-miR-486SmoHedgehog/GlI2[88]
NK cells-derived exo-miR-223ATG7Autophagy pathway [85]
KCs-derived exo-miR-690NADK -[84]
lncRNA SNHGmiR-15a, MURF1 UVRAG/ATG5/Wnt5a [93]
lncRNA BIHAA1miR-667-5p-[92]
MSCs-derived exo-circDIDO1miR-141-3p PTEN/AKT[73]
MSCs-derived exo-circCDK13miR-17-5p, KAT2BPI3K/AKT, NF-κB[94]